This brand name is authorized in Cyprus, Malta, Singapore
The drug FELEXIN contains one active pharmaceutical ingredient (API):
1
Cefalexin
UNII 5SFF1W6677 - CEPHALEXIN ANHYDROUS
|
Cefalexin is an antibacterial agent of the cephalosporin class. Like other cephalosporins cefalexin exerts antibacterial activity by binding to and inhibiting the action of penicillin-binding proteins involved in the synthesis of bacterial cell walls. This leads to bacterial cell lysis and cell death. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
FELEXIN Hard capsule | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
FELEXIN Powder for oral suspension | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
J01DB01 | Cefalexin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DB First-generation cephalosporins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: MT | Medicines Authority | Identifier(s): AA084/09102 |
Country: SG | Health Sciences Authority | Identifier(s): 00449P, 09472P, 09477P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.